COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study LYW Lee, JB Cazier, V Angelis, R Arnold, V Bisht, NA Campton, ... The Lancet 395 (10241), 1919-1926, 2020 | 1221 | 2020 |
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study LYW Lee, JB Cazier, T Starkey, SEW Briggs, R Arnold, V Bisht, S Booth, ... The Lancet Oncology 21 (10), 1309-1316, 2020 | 635 | 2020 |
2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity PL Sulkowski, CD Corso, ND Robinson, SE Scanlon, KR Purshouse, ... Science translational medicine 9 (375), eaal2463, 2017 | 533 | 2017 |
The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancer LL da Motta, I Ledaki, K Purshouse, S Haider, MA De Bastiani, D Baban, ... Oncogene 36 (1), 122-132, 2017 | 159 | 2017 |
The UK Coronavirus Cancer Monitoring Project: protecting patients with cancer in the era of COVID-19 UK Coronavirus Cancer Monitoring Project team The Lancet. Oncology 21 (5), 622, 2020 | 69 | 2020 |
COVID-19 and cancer registries: learning from the first peak of the SARS-CoV-2 pandemic AJX Lee, K Purshouse British Journal of Cancer 124 (11), 1777-1784, 2021 | 62 | 2021 |
Mortality among adults with cancer undergoing chemotherapy or immunotherapy and infected with COVID-19 C Várnai, C Palles, R Arnold, HM Curley, K Purshouse, VWT Cheng, ... JAMA network open 5 (2), e220130-e220130, 2022 | 55 | 2022 |
Challenges to DNA replication in hypoxic conditions N Ng, K Purshouse, IP Foskolou, MM Olcina, EM Hammond The FEBS journal 285 (9), 1563-1571, 2018 | 52 | 2018 |
Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID‐19: disease control as an important factor relative to recent chemotherapy or anti … S Booth, HM Curley, C Varnai, R Arnold, LYW Lee, NA Campton, G Cook, ... British Journal of Haematology 196 (4), 892-901, 2022 | 32 | 2022 |
Toxic epidermal necrolysis in a patient receiving vemurafenib for treatment of metastatic malignant melanoma R Sinha, K Lecamwasam, K Purshouse, J Reed, MR Middleton, ... British Journal of Dermatology 170 (4), 997-999, 2014 | 32 | 2014 |
Value of supraregional multidisciplinary review for the contemporary management of testicular tumors K Purshouse, RA Watson, DN Church, C Richardson, G Crane, Z Traill, ... Clinical Genitourinary Cancer 15 (1), 152-156, 2017 | 28 | 2017 |
Endo180 modulation by bisphosphonates and diagnostic accuracy in metastatic breast cancer C Palmieri, MP Caley, K Purshouse, AV Fonseca, M Rodriguez-Teja, ... British journal of cancer 108 (1), 163-169, 2013 | 26 | 2013 |
Distinguishing between direct and indirect consequences of covid-19 JD Figueroa, PM Brennan, E Theodoratou, MTC Poon, K Purshouse, ... Bmj 369, 2020 | 22 | 2020 |
UK Coronavirus Monitoring Project Team: COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: A prospective cohort study LY Lee, JB Cazier, V Angelis, R Arnold, V Bisht, NA Campton, ... Lancet 395 (10/241), 1919-1926, 2020 | 20 | 2020 |
Immune checkpoint blockade: releasing the breaks or a protective barrier to COVID-19 severe acute respiratory syndrome? OJ Pickles, LYW Lee, T Starkey, L Freeman-Mills, A Olsson-Brown, ... British journal of cancer 123 (5), 691-693, 2020 | 19 | 2020 |
Oncogene expression from extrachromosomal DNA is driven by copy number amplification and does not require spatial clustering in glioblastoma stem cells K Purshouse, ET Friman, S Boyle, PS Dewari, V Grant, A Hamdan, ... Elife 11, e80207, 2022 | 17 | 2022 |
UK Coronavirus Cancer Monitoring Project Team COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a … LYW Lee, JB Cazier, T Starkey, SEW Briggs, R Arnold, V Bisht, S Booth, ... Lancet Oncol 21 (10), 1309-1316, 2020 | 15 | 2020 |
Whole-genome sequencing identifies homozygous BRCA2 deletion guiding treatment in dedifferentiated prostate cancer K Purshouse, A Schuh, BP Fairfax, S Knight, P Antoniou, H Dreau, ... Molecular Case Studies 3 (3), a001362, 2017 | 13 | 2017 |
Trends in excess cancer and cardiovascular deaths in Scotland during the COVID-19 pandemic 30 December–20 April suggest underestimation of COVID-19 related deaths JD Figueroa, P Brennan, E Theodoratou, M Poon, K Purshouse, F Din, ... medRxiv, 2020.05. 02.20086231, 2020 | 11 | 2020 |
A phase I study to assess the safety and tolerability of intravesical pembrolizumab in recurrent non-muscle invasive bladder cancer (NMIBC). VK Woodcock, K Purshouse, C Butcher, C Haddon, G Verrall, L Elhussein, ... Journal of Clinical Oncology 37 (7_suppl), 406-406, 2019 | 10 | 2019 |